Tower Research Capital LLC (TRC) - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 3 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$60,442
-26.9%
13,284
+13.2%
0.00%
-33.3%
Q2 2023$82,629
+108622.4%
11,737
-6.5%
0.00%
+50.0%
Q1 2023$76
-62.2%
12,550
-60.2%
0.00%
-75.0%
Q4 2022$201
-100.0%
31,539
-43.9%
0.01%
-11.1%
Q3 2022$539,000
+91.8%
56,267
+120.8%
0.01%
+50.0%
Q2 2022$281,000
+485.4%
25,484
+787.3%
0.01%
Q1 2022$48,000
+700.0%
2,872
+715.9%
0.00%
Q4 2021$6,000
-64.7%
352
-46.2%
0.00%
Q3 2021$17,000
-81.5%
654
-81.4%
0.00%
-100.0%
Q2 2021$92,000
-96.7%
3,519
-96.0%
0.00%
-95.7%
Q1 2021$2,765,000
+68.4%
87,355
+146.9%
0.05%
-6.0%
Q4 2020$1,642,000
+1257.0%
35,380
+862.7%
0.05%
+4900.0%
Q3 2020$121,000
-80.6%
3,675
-83.9%
0.00%
-96.2%
Q2 2020$625,000
+7712.5%
22,778
+8006.0%
0.03%
+2500.0%
Q4 2019$8,000
-92.9%
281
-95.4%
0.00%
-87.5%
Q3 2019$112,000
+286.2%
6,157
+413.1%
0.01%
+300.0%
Q2 2019$29,000
-70.7%
1,200
-86.4%
0.00%
-71.4%
Q3 2018$99,000
+518.8%
8,842
+625.3%
0.01%
+600.0%
Q2 2018$16,000
+1500.0%
1,219
+2157.4%
0.00%
Q1 2018$1,000
-80.0%
54
-92.0%
0.00%
-100.0%
Q4 2017$5,000
-93.0%
672
-92.7%
0.00%
-83.3%
Q3 2017$71,000
+3450.0%
9,190
+3193.9%
0.01%
Q2 2017$2,0002790.00%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 2,222,701$25,005,0008.92%
Broadfin Capital, LLC 4,894,361$55,062,0008.10%
GREAT POINT PARTNERS LLC 3,496,340$39,334,0006.13%
FRAZIER MANAGEMENT LLC 2,188,331$24,619,0004.51%
Prosight Management, LP 715,317$8,047,0004.49%
Avoro Capital Advisors LLC 8,662,720$97,456,0004.48%
QVT Financial LP 821,361$8,748,0002.26%
Perceptive Advisors 7,290,199$82,014,0002.19%
Rhenman & Partners Asset Management AB 1,290,495$14,518,0001.46%
EMORY UNIVERSITY 185,915$2,092,0001.37%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders